Patient preferences for pilonidal sinus treatments: A discrete choice experiment survey

被引:8
|
作者
Wickramasekera, Nyantara [1 ]
Strong, Emily [2 ]
Shackley, Philip [1 ]
Callaghan, Tia [2 ]
Lee, Matthew [3 ,4 ]
Hind, Daniel [2 ]
Brown, Steven [2 ,3 ]
机构
[1] Regent Court, Sch Hlth & Related Res, Sheffield, England
[2] Univ Sheffield, Clin Trials Res Unit, Regent Court, Sheffield, England
[3] Northern Gen Hosp, Dept Gen Surg, Sheffield, England
[4] Univ Sheffield, Med Sch, Dept Oncol & Metab, Sheffield, England
关键词
discrete choice experiment; patient preference; pilonidal sinus; shared decision making; HEALTH-CARE;
D O I
10.1111/codi.16482
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim: A range of treatments are available for pilonidal sinus disease (PSD), each of which has a different risk/benefit profile. The aim of this study was to collect patient views on which interventions they would rather avoid and which outcomes they most value for PSD.Method: We conducted an online survey using the discrete choice experiment (DCE) method. The DCE task involved participants choosing the best treatment option when presented with a set of competing hypothetical treatment profiles. Participants with symptomatic PSD referred for elective surgery were recruited from 33 National Health Service trusts between 2020 and 2022. Collected DCE data were analysed using regression analyses.Results: In all, 111 participants completed the survey. In the overall group, low risk of infection/persistence was the most important characteristic when making a treatment decision (attribute importance score 70%), followed by treatments with shorter recovery time with an attribute importance score of 30%. The results demonstrated that patients are willing to accept trade-offs between treatment recovery time and risk of infection/persistence. Patients above 30 years old are willing to accept a higher chance of treatment failure in exchange for rapid treatment recovery (risk tolerance between 22.35 and 34.67 percentage points). Conversely, patients in the younger age groups were risk averse and were only willing to accept a small risk of 1.51-2.15 in exchange for a treatment with faster recovery time. All patient groups appear to the reject the excision and leave open technique due to the need for protracted nursing care.Conclusion: This study highlights the need for shared decision making when it comes to surgery for PSD.
引用
收藏
页码:984 / 994
页数:11
相关论文
共 50 条
  • [21] Patient Preferences for Attributes of Biologic Treatments in Moderate to Severe Asthma: A Discrete Choice Experiment Study
    Yang, Min
    Chao, Jingdong
    Fillbrunn, Mirko
    Mallya, Usha G.
    Wang, Min -Jung
    Franke, Leigh
    Cohn, Lauren
    Kamat, Siddhesh
    PATIENT PREFERENCE AND ADHERENCE, 2022, 16 : 2649 - 2661
  • [22] Patient preferences for breast cancer treatments: a discrete choice experiment in France, Ireland, Poland, Spain
    Stamuli, Eugena
    Corry, Sorcha
    Ross, Derek
    Konstantopoulou, Thomais
    FUTURE ONCOLOGY, 2022, 18 (09) : 1115 - 1132
  • [23] Patient preferences for specialist outpatient video consultations: A discrete choice experiment
    Snoswell, Centaine L.
    Smith, Anthony C.
    Page, Matthew
    Caffery, Liam J.
    JOURNAL OF TELEMEDICINE AND TELECARE, 2021, : 707 - 715
  • [24] Patient preferences for treatment of lumbar disc herniation: a discrete choice experiment
    Gadjradj, Pravesh S.
    Smeele, Nicholas V. R.
    de Jong, Mandy
    Depauw, Paul R. A. M.
    van Tulder, Maurits W.
    de Bekker-Grob, Esther W.
    Harhangi, Biswadjiet S.
    JOURNAL OF NEUROSURGERY-SPINE, 2022, 36 (05) : 704 - 712
  • [25] Patient preferences for conservative treatment of shoulder pain: a discrete choice experiment
    Versloot, Annelotte H. C.
    Veldwijk, Jorien
    Ottenheijm, Ramon P. G.
    de Graaf, Marloes
    van der Windt, Danielle A.
    Koes, Bart W.
    Runhaar, Jos
    Schiphof, Dieuwke
    FAMILY PRACTICE, 2024,
  • [26] Patient Preferences for Pharmaceutical and Device-Based Treatments for Uncontrolled Hypertension: Discrete Choice Experiment
    Kandzari, David E. E.
    Weber, Michael A. A.
    Poulos, Christine
    Coulter, Joshua
    Cohen, Sidney A. A.
    DeBruin, Vanessa
    Jones, Denise
    Pathak, Atul
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2023, 16 (01): : E008997
  • [27] Patient preferences for first-line treatment of classical Hodgkin lymphoma: a US survey and discrete choice experiment
    Khan, Niloufer
    Feliciano, Joseph
    Mueller, Kerstin
    He, Mary
    Tao, Rei
    Korol, Ellen
    Dalal, Mehul
    Rebeira, Mayvis
    Matasar, Matthew
    LEUKEMIA & LYMPHOMA, 2020, 61 (11) : 2630 - 2637
  • [28] Discrete Choice Experiment to Understand Japanese Patients' and Physicians' Preferences for Preventive Treatments for Migraine
    Seo, Jaein
    Tervonen, Tommi
    Ueda, Kaname
    Zhang, Dian
    Danno, Daisuke
    Tockhorn-Heidenreich, Antje
    NEUROLOGY AND THERAPY, 2023, 12 (02) : 651 - 668
  • [29] Elicitation of societal preferences for chronic lymphocytic leukemia's treatments: a discrete choice experiment
    Borsoi, Ludovica
    Costa, Francesco
    Milano, Carlo
    Segantin, Gaia
    Ghia, Paolo
    Armeni, Patrizio
    LEUKEMIA & LYMPHOMA, 2024, 65 (11) : 1565 - 1575
  • [30] Patient and physician preferences for treatment of hepatitis C virus infection in Japan: a discrete choice experiment
    Nakamoto, Daisuke
    Piao, Yi
    Mizutani, Hajime
    Lopresti, Michael
    Chikamura, Yunosuke
    Makhija, Dilip
    Kwon, Kyung min
    Zagorski, Jamie
    Jinushi, Masahisa
    Eguchi, Yuichiro
    JOURNAL OF MEDICAL ECONOMICS, 2025, 28 (01) : 524 - 534